Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases

被引:13
作者
Enkvist, Erki [1 ]
Kriisa, Marie [1 ]
Roben, Mart [1 ]
Kadak, Grete [1 ]
Raidaru, Gerda [1 ]
Uri, Asko [1 ]
机构
[1] Univ Tartu, Inst Chem, EE-51014 Tartu, Estonia
关键词
Protein kinases; AGC kinases; PKA; PKB/Akt; ROCK; Bisubstrate inhibitors; Oligoarginine; PEPTIDE INHIBITORS; DISCOVERY; DESIGN; AKT;
D O I
10.1016/j.bmcl.2009.09.026
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Previously reported structural fragments that associate with the ATP-binding pocket of basophilic protein kinases were conjugated with D-arginine-containing peptides. Inhibitory potency of the resulting bisubstrate-analog inhibitors towards PKA and ROCK-II extended to subnanomolar range. The conjugates incorporating 2-pyrimidyl-5-amidothiophene fragment had the highest activity and at 100 nM concentration exhibited over 80% inhibition of most of the tested basophilic kinases of the AGC group. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6098 / 6101
页数:4
相关论文
共 17 条
[1]   ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II [J].
Ahn, Dae-Ro ;
Han, Ki-Cheol ;
Kwon, Hyuk Sung ;
Yang, Eun Gyeong .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) :147-151
[2]   Peptide inhibitors of protein kinases - discovery, characterisation and use [J].
Bogoyevitch, MA ;
Barr, RK ;
Ketterman, AJ .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2) :79-99
[3]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[4]   Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases [J].
Enkvist, Erki ;
Lavogina, Darja ;
Raidaru, Gerda ;
Vaasa, Angela ;
Viil, Indrek ;
Lust, Marje ;
Viht, Kaido ;
Uri, Asko .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :7150-7159
[5]   The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases [J].
Fischer, PM .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (12) :1563-1583
[6]   Protein kinase inhibitors: contributions from structure to clinical compounds [J].
Johnson, Louise N. .
QUARTERLY REVIEWS OF BIOPHYSICS, 2009, 42 (01) :1-40
[7]   Structural Analysis of ARC-Type Inhibitor (ARC-1034) Binding to Protein Kinase A Catalytic Subunit and Rational Design of Bisubstrate Analogue Inhibitors of Basophilic Protein Kinases [J].
Lavogina, Darja ;
Lust, Marje ;
Viil, Indrek ;
Koenig, Norbert ;
Raidaru, Gerda ;
Rogozina, Jevgenia ;
Enkvist, Erki ;
Uri, Asko ;
Bossemeyer, Dirk .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :308-321
[8]   Stepwise combinatorial evolution of Akt bisubstrate inhibitors [J].
Lee, Jung Hwan ;
Kumar, Sanjai ;
Lawrence, David S. .
CHEMBIOCHEM, 2008, 9 (04) :507-509
[9]   Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies [J].
Lin, Xiaodong ;
Murray, Jeremy M. ;
Rico, Alice C. ;
Wang, Michael X. ;
Chu, Daniel T. ;
Zhou, Yasheen ;
Del Rosario, Merci ;
Kaufman, Susan ;
Ma, Sylvia ;
Fang, Eric ;
Crawford, Kenneth ;
Jefferson, A. B. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) :4163-4168
[10]   Designing bisubstrate analog inhibitors for protein kinases [J].
Parang, K ;
Cole, PA .
PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) :145-157